ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“Less than 2 weeks left to submit your abstract to ESMOTATAsia25!
A fantastic opportunity to showcase your transformative work within the region in a truly international platform.
Submit your research in cancer drug development by 29 April by 18:00 Hong Kong Time.”